Eurofins Scientific SE

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:35:07 2025-06-20 am EDT			5-day change	1st Jan Change
59.50 ^EUR	+0.10%		-1.36%	+20.67%

May. 19	Eurofins Scientific SE acquired PLANTON GmbH from Michael Kleine and others.	CI
Apr. 30	The stock market has just gained 15% but remains in the fog

Eurofins Q1 Revenues At EUR 1.77 Bln

Published on 04/23/2025 at 01:18

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eurofins Scientific SE

Eurofins Scientific SE acquired PLANTON GmbH from Michael Kleine and others.	May. 19	CI
The stock market has just gained 15% but remains in the fog	Apr. 30
Five sessions of gains in Trump's first 100 days	Apr. 29
The stock market returns to "Risk On"	Apr. 25
HSBC Downgrades Eurofins Scientific to Hold, Cuts PT	Apr. 25	MT
Eurofins Scientific SE commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 24, 2025.	Apr. 25	CI
Eurofins Scientific To Buy Back Max. 4.5% Of Its Shares	Apr. 25	RE
Eurofins Scientific SE 's Equity Buyback announced on September 2, 2024 has expired.	Apr. 23	CI
EUROFINS SCIENTIFIC : Reiterated outlook impresses investors	Apr. 23
Eurofins Scientific SE, Q1 2025 Sales/ Trading Statement Call, Apr 23, 2025	Apr. 23
Eurofins: Q1 sales up nearly 7%	Apr. 23	CF
Eurofins Q1 Revenues At EUR 1.77 Bln	Apr. 23	RE
Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on September 2, 2024.	Apr. 23	CI
Eurofins: completes refinancing of hybrid bonds	Apr. 03	CF
Eurofins Announces the Success of Its Tender Offer on Its ?400 Million Hybrid Bond	Apr. 03	CI
EUROFINS : Jefferies still a seller, but raises TP	Apr. 01	CF
Eurofins Scientific Completes Purchase of Synlab's Spanish Clinical Diagnostics Operations	Apr. 01	MT
Eurofins: acquisition of Synlab business in Spain	Apr. 01	CF
Eurofins Scientific Closes Acquisition Of SYNLAB's Clinical Diagnostics Operations In Spain	Apr. 01	RE
Eurofins Scientific SE completed the acquisition of clinical diagnostics operations in Spain from SYNLAB AG.	Mar. 30	CI
Eurofins: successful hybrid bond issue	Mar. 28	CF
Eurofins Raises EUR400 Million from Hybrid Bond Offer	Mar. 28	MT
French company Eurofins raises 400 mln euros via hybrid bond issue	Mar. 27	RE
Eurofins Plans Issuance, Tender Offer for New, Old Hybrid Bonds	Mar. 26	MT
Eurofins: issues a new hybrid bond	Mar. 26	CF

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2024, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (51%), North America (38.3%) and other (10.7%).

Employees

62,696

Sector

Biotechnology & Medical Research

Calendar

Jul. 23 - Q2 2025 Earnings Release

More about the company